Anti-CD20 monoclonal antibodies have become central therapies for multiple sclerosis (MS) and other autoimmune disorders of the central nervous system, including neuromyelitis optica spectrum disorder (NMOSD), myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), and autoimmune encephalitis. These ag...
D. Ferraro, G. Abbadessa, Federica Azzolini et al.· Neurological Therapeutics· 0 citations
The neuropathological and imaging evidence linking cortical pathology to meningeal inflammation, neuroaxonal injury and progression independent of relapse activity is examined, and how emerging magnetic resonance imaging approaches for detecting and monitoring cortical lesions contribute to diagnosis and prognosis acro...
Massimiliano Calabrese, Roberta Magliozzi, Agnese Tamanti et al.· Nature Reviews Neurology· 0 citations
CP volume was increased in both active RMS and inactive PMS and was associated with lower total and cortical brain volumes, suggesting CP volume may reflect processes beyond MS-specific pathology, including physiological factors.
M. Mastantuono, A. Cagol, M. Ocampo-Pineda et al.· Multiple Sclerosis· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.